Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:31 AM
Ignite Modification Date:
2025-12-25 @ 3:31 AM
NCT ID:
NCT03039205
Eligibility Criteria:
Inclusion Criteria:
* Patients in use of aspirin for at least 7 days prior to randomization;
* Documented obstructive coronary artery disease by angiography;
* At least 12 months from the last episode of myocardial infarction (MI);
* Agree to sign the Informed Consent.
Exclusion Criteria:
* Prior ischemic or hemorrhagic stroke;
* Prior intracranial bleeding;
* Use of oral anticoagulant in the past month;
* Use of dual antiplatelet therapy in the last 30 days;
* Use of NSAIDs and / or dipyridamole in the past month;
* Mandatory use of proton pump inhibitor;
* Known platelet dysfunction or platelets \<100,000 or \>450,000/μL;
* End-stage renal disease undergoing hemodialysis;
* Terminal illness;
* Known liver disease or coagulation disorder;
* Known pregnancy, breast-feeding, or intend to become pregnant during the study period;
* Hypersensitivity to clopidogrel, ticagrelor or any excipients;
* Refusal to sign the Informed Consent;
* Active pathological bleeding.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03039205
Study Brief:
Protocol Section:
NCT03039205